Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease

Acta Neuropathologica

Volumn 104, Issue 5, 2002, Pages 525-533

  Rensink, Annemieke A M ^a,b   Gellekink, Henkjan ^a,b   Otte Höller, Irene ^b   ten Donkelaar, Hans J ^a   de Waal, Robert M W ^b   Verbeek, Marcel M ^a   Kremer, Berry ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Amyloid ; Inflammation; Insulin like growth factor binding protein 3; Leukemia inhibitory factor

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENTARY DNA; CYTOKINE; DNA; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; RNA; SOMATOMEDIN BINDING PROTEIN 3; TRANSCRIPTION FACTOR EGR 1;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ASTROCYTE; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE; VASCULAR AMYLOIDOSIS;

EID: 0036938331     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-002-0585-x     Document Type: Article

References (36)

1. Bauer J, Garter U, Strauss S, Stadtmuller G, Frommberger U, Bauer H, Volk B, Berger M (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer's disease. Res Immunol 143:650-657
2. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger BR, Kley N (1995) Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649
3. Bugga L, Gadient RA, Kwan K, Stewart CL, Patterson PH (1998) Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor. J Neurobiol 36: 509-524
4. Cheema SS, Richards LJ, Murphy M, Bartlett PF (1994) Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death. Neuroreport 5:989-992
5. Cheng JG, Patterson PH (1997) LIF is an autocrine factor for sympathic neurons. Mol Cell Neurosci 9:372-380
6. Davis J, Van Nostrand WE (1996) Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein. Proc Natl Acad Sci USA 93:2996-3000
7. Davis-Salinas J, Van Nostrand WE (1995) Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem 270:20887-20890
8. Dieckgraefe BK, Weems DM (1999) Epithelial injury induces egr- 1 and fos expression by a pathway involving protein kinase C and ERK. Am J Physiol 276:G322-G330
9. Dore S, Kar S, Quirion R (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid-and human amylin-induced toxicity. Proc Natl Acad Sci USA 94:4772-4777
10. Eikelenboom P, Zhan SS, Gool WA van, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15:447-450
11. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890
12. Griffin WS, Sheng JG, Roberts GW, Mrak RE (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J Neuropathol Exp Neurol 54:276-281
13. Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res 623:142-146
14. Khachigian LM, Collins T (1998) Early growth response factor 1: a pleiotropic mediator of inducible gene expression. J Mol Med 76:613-616
15. Knight DA, Lydell CP, Zhou D, Weir TD, Robert-Schellenberg R, Bai TR (1999) Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release. Am J Respir Cell Mol Biol 20:834-841
16. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA (1991) An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci USA 88:7247-7251
17. Kurek JB, Radford AJ, Crump DE, Bower JJ, Feeney SJ, Austin L, Byrne E (1998) LIF (AM424), a promising growth factor for the treatment of ALS. J Neurol Sci 160 (Suppl 1): S106-S113
18. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, Van Duinen SG, Bots GT, Luyendijk W, Frangione B (1990) Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248:1124-1126
19. Melchor JP, Van Nostrand WE (2000) Fibrillar amyloid beta-protein mediates the pathologic accumulation of its secreted precursor in human cerebrovascular smooth muscle cells. J Biol Chem 275:9782-9791
20. Mi H, Haeberle H, Barres BA (2001) Induction of astrocyte differentiation by endothelial cells. J Neurosci 21:1538-1547
21. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486
22. Murphy M, Dutton R, Koblar S, Cheema S, Bartlett P (1997) Cytokines which signal through the LIF receptor and their actions in the nervous system. Prog Neurobiol 52:355-378
23. Muthukkumar S, Han SS, Rangnekar VM, Bondada S (1997) Role of Egr-1 gene expression in B cell receptor-induced apoptosis in an immature B cell lymphoma. J Biol Chem 272: 27987-27993
24. Nair P, Muthukkumar S, Sells SF, Han SS, Sukhatme VP, Rangnekar VM (1997) Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem 272:20131-20138
25. Ocrant I, Fay CT, Parmelee JT (1990) Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system. Endocrinology 127:1260-1267
26. Shen L, Dean NM, Glazer RI (1999) Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase Calpha antisense oligonucleotide. Mol Pharmacol 55:396-402
27. Subang MC, Richardson PM (2001) Synthesis of leukemia inhibitory factor in injured peripheral nerves and their cells. Brain Res 900:329-331
28. Sugiura S, Lahav R, Han J, Kou SY, Banner LR, De Pablo F, Patterson PH (2000) Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci 12:457-466
29. Van Nostrand WE, Melchor JP, Ruffini L (1998) Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J Neurochem 70:216-223
30. Verbeek MM, Otte H, I, Wesseling P, Ruiter DJ, De Waal RM (1994) Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol 144:372-382
31. Verbeek MM, De Waal RM, Schipper JJ, Van Nostrand WE (1997) Rapid degeneration of cultured human brain pericytes by amyloid beta protein. J Neurochem 68:1135-1141
32. Verbeek MM, Eikelenboom P, De Waal RM (1997) Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J Neuropathol Exp Neurol 56:751-761
33. Verbeek MM, Van Nostrand WE, De Waal RMW (2000) Degeneration of human cerebrovascular smooth muscle cells and pericytes caused by amyloid β protein. In: Verbeek MM, De Waal RMW, Vinters HV (eds) Cerebral amyloid angiopathy in Alzheimer's disease and related disorders. Kluwer, Dordrecht, pp 265-279
34. Weller RO, Massey A, Kuo YM, Roher AE (2000) Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann N Y Acad Sci 903:110-117
35. Wisniewski HM, Wegiel J, Wang KC, Lach B (1992) Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 84:117-127
36. Zhu M, Oishi K, Lee SC, Patterson PH (2001) Studies using Leukemia inhibitory factor (LIF) knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation. J Immunol 166:2049-2054